eISSN: 1643-3750

Logo




Get your full text copy in PDF

Brain natriuretic peptide is a reliable indicator of ventilatory abnormalities during cardiopulmonary exercise test in heart failure patients.

Angela Beatrice Scardovi, Renata De Maria, Claudio Coletta, Nadia Aspromonte, Silvia Perna, Tommaso Infusino, Stefano Rosato, Manuela Greggi, Tiziana Di Giacomo, Roberto Ricci, Vincenzo Ceci

Med Sci Monit 2006; 12(5): CR191-195

ID: 450286


Background: Whether brain natriuretic peptide (BNP), a neurohormone markerof ventricular dysfunction, correlates with an enhanced ventilatory response (EVR) during cardiopulmonaryexercise test, a well-known predictor of prognosis, in systolic heart failure (HF) is currently unknown.Material/Methods: Resting BNP was measured in 134 consecutive stable outpatients aged 69+/-11 years withmild to moderate HF and LV ejection fraction (LVEF) /=35. Results: LVEF averaged 33+/-7%, BNP 350+/-396 pg/ml, and the VE/VCO[sub]2[/sub] slope 36+/-8. Fifty-sixof 123 patients (45%) had EVR. BNP correlated with VE/VCO[sub]2[/sub] slope (r=0.453; p

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree